PUKYONG

Purification and characterization of antimicrobial peptides from Skipjack tuna, Katsuwonus pelamis and Pacific oyster, Crassostrea gigas

Metadata Downloads
Alternative Title
가다랑어와 태평양 굴로부터 항균 펩타이드의 정제 및 특성
Abstract
Part 1. A 2.3 kDa of antimicrobial peptide was purified from an acidified liver extract of skipjack tuna, Katsuwonus pelamis, by preparative continuous acid-urea–polyacrylamide gel electrophoresis and C18 reversed-phase HPLC. A comparison of the amino acid sequence of the purified peptide with those of other known polypeptides revealed high homology with the C-terminus of hemoglobin β-chain; thus, this peptide was designated as the Skipjack hemoglobin β chain-related antimicrobial peptide (SHβAP). SHβAP showed potent antimicrobial activity against Gram-positive bacteria, such as Bacillus subtilis, Staphylococcus aureus, and Streptococcus iniae (minimal effective concentrations [MECs], 6.5-57.0 μg/mL), Gram-negative bacteria, such as Escherichia coli D31, Pseudomonas aeruginosa, Salmonella enterica, Shigella sonnei, and two Vibrio parahaemolyticus (MECs, 2.0-19.0 μg/mL), and against C. albicans (MEC; 12.0 μg/mL) without significant hemolytic activity. Antimicrobial activity of this peptide was heatstable and pH resistant but protease and salt-sensitive. SHβAP did not show membrane permeabilization and killing ability. The secondary structural prediction and the homology modeling expected that this peptide formed an amphipathic α–helical structure. This is the first report the purification of a novel antimicrobial peptide related to the C-terminus of hemoglobin β–chain from marine fish.
Part 2. An antimicrobial polypeptide was purified from an acidified gill extract of Pacific oyster (Crassostrea gigas) by C18 reversed-phase HPLC. The purified polypeptide had a molecular weight of 8,471 Da containing 74 amino acid residues. Comparison of the obtained N-terminal sequences with those of others revealed that it was identical to ubiquitin reported from other species and named cgUbiquitin. cgUbiquitin showed broad potent antimicrobial activity against Gram-positive and Gram-negative bacteria including Streptococcus iniae and Vibrio parahaemolyticus (minimal effective concentrations, 7.8 and 9.8 μg/mL), respectively, without hemolytic activity. The cgUbiquitin cDNA was identified from an EST library of oyster gill as a precursor form, encoding ubiquitin consisting of 76 amino acids fused to ribosomal protein of S27. Although the cgUbiquitin precursor mRNA was expressed at the intermediate level in the gill, the mRNA was significantly up-regulated at 48 h post injection with Vibrio sp. Analysis of the cgUbiquitin C-terminus by carboxypeptidase B treatment and comparison of the retention times revealed that cgUbiquitin lacks the terminal Gly-Gly doublet and ends in an C-terminal Arg residue which might be related to antimicrobial activity. Study of the kinetics of killing and membrane permeabilization showed that this peptide was not membrane permeable and acted through a bacteriostatic process. According to the homology modeling, this peptide is composed of three secondary structural motifs including three α-helices and four β-strands separated by 7 loops regions. Our results indicate that cgUbiquitin might be related to the innate immune defenses in the Pacific oyster and this is the first report for antimicrobial function of ubiquitin isolated from any oyster species.
Author(s)
Min Jeong Lee
Issued Date
2013
Awarded Date
2013. 2
Type
Dissertation
Publisher
부경대학교
URI
https://repository.pknu.ac.kr:8443/handle/2021.oak/24703
http://pknu.dcollection.net/jsp/common/DcLoOrgPer.jsp?sItemId=000001966081
Alternative Author(s)
이 민정
Affiliation
부경대학교 대학원
Department
대학원 생물공학과
Advisor
박남규
Table Of Contents
PART Ⅰ.
Antimicrobial Function of SHβAP, a Novel Hemoglobin β Chain-Related Antimicrobial Peptide, Isolated from the Liver of Skipjack Tuna, Katsuwonus Pelamis
List of tables ···················································································· 2
List of figures ··················································································· 2
Korean abstract ··············································································· 4
1.1. Introduction ··············································································· 5
1.2. Materials and Methods
1.2.1. Tissue extraction ······································································ 9
1.2.2. Proteolytic digestion of the crude extract to determine if the antimicrobial compounds were proteinaceous ···················································· 9
1.2.3. Ultrasensitive radial diffusion assay (URDA) ································· 10
1.2.4. Hemolytic Assay ····································································· 11
1.2.5. Acid-urea PAGE (AU–PAGE) ····················································· 12
1.2.6. Continuous AU–PAGE ····························································· 13
1.2.7. Reversed-phase HPLC ····························································· 14
1.2.8. Determination of the amino acid sequence and molecular weight of the purified peptide ··································································· 14
1.2.9. Sequence analysis ··································································· 15
1.2.10. Peptide synthesis ··································································· 15
1.2.11. Determination of the C-terminus modification by RP-HPLC ············· 16
1.2.12. Salt effect on the antimicrobial activity of the peptides ···················· 16
1.2.13. Effects of pH, temperature, and protease on the antimicrobial activity 17
1.2.14. Killing assays ······································································· 18
1.2.15. Membrane permeabilization assays ··········································· 18
1.2.16. Preparation of liposomes ························································ 19
1.2.17. Leakage of calcein from liposomes ············································ 20
1.2.18. Structural modeling ······························································· 21
1.3. Results and Discussion
1.3.1. Peptide purification ································································· 22
1.3.2. Peptide identification ······························································· 23
1.3.3. Primary structure relationships ·················································· 23
1.3.4. Determination of the C-terminus modification of SHβAP ·················· 24
1.3.5. Antimicrobial and hemolytic activities ·········································· 31
1.3.6. Salt effect on the antibacterial activity of the peptides ······················ 32
1.3.7. Effects of pH, temperature, and protease on the antimicrobial activity ·· 33
1.3.8. Membrane permeabilization ability of the antimicrobial peptide ········· 34
1.3.9. Killing kinetic study of the antimicrobial peptide ····························· 35
1.3.10. Leakage ability of SHβAP ······················································· 36
1.3.11. Prediction of the secondary structure ········································· 37
1.3.12. Structural modeling ······························································· 38
Summary ······················································································· 52
References ····················································································· 53

PART Ⅱ.
Purification and Antimicrobial Function of Ubiquitin Isolated from the Gill of Pacific Oyster, Crassostrea Gigas
List of table ···················································································· 61
List of figures ················································································· 61
Korean abstract ·············································································· 63
2.1. Introduction ·············································································· 64
2.2. Materials and Methods
2.2.1. Tissue extraction ····································································· 67
2.2.2. Proteolytic digestion of crude extract to determine if antimicrobial compounds were proteinaceous ················································ 67
2.2.3. Microbial strains and culture conditions ······································· 68
2.2.4. Ultrasensitive radial diffusion assay (URDA) ································· 68
2.2.5. Reversed-phase HPLC ····························································· 70
2.2.6. Molecular weight measurement and amino acid sequencing of the purified polypeptide ········································································· 70
2.2.7. Quantification of the purified polypeptide ····································· 71
2.2.8. Hemolytic Assay ····································································· 71
2.2.9. Cloning of ubiquitin precursor-encoding cDNAs ····························· 72
2.2.10. Real-time quantitative PCR ······················································ 75
2.2.11. Sequence analysis ·································································· 75
2.2.12. Killing assays ······································································· 75
2.2.13. Membrane permeabilization assays ··········································· 76
2.2.14. C-terminal analysis of cgUbiquitin ············································ 77
2.2.15. Structural modeling ······························································· 78
2.3. Results
2.3.1 Peptide Purification ································································· 79
2.3.2. Peptide Identification ······························································· 82
2.3.3. Antibacterial and hemolytic activities ··········································· 82
2.3.4. cDNA sequence and phylogenetic analysis of cgUbiquitin ················· 83
2.3.5. Expression of the cgUbiquitin mRNAs ·········································· 84
2.3.6. C-terminal analysis of cgUbiquitin ·············································· 84
2.3.7 Action mode of cgUbiquitin ························································ 85
2.3.8. Structural modeling ································································· 86
2.4. Discussion ·············································································· 100
Summary ····················································································· 108
References ···················································································· 109

Published & Submitted papers ························································· 118

감사의 글 ···················································································· 119
Degree
Master
Appears in Collections:
대학원 > 생물공학과
Authorize & License
  • Authorize공개
Files in This Item:

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.